Presentation is loading. Please wait.

Presentation is loading. Please wait.

By Amany Helmy Hasanin Assistant Professor of Clinical Pharmacology

Similar presentations


Presentation on theme: "By Amany Helmy Hasanin Assistant Professor of Clinical Pharmacology"— Presentation transcript:

1 By Amany Helmy Hasanin Assistant Professor of Clinical Pharmacology
Pharmacodynamic-1 By Amany Helmy Hasanin Assistant Professor of Clinical Pharmacology

2 Welcome to Pharmacology

3 Pharmacology Science deals with drugs Nature Body's reaction to drugs
Drug's reaction to body Therapeutic uses (Indications) Adverse drug reactions (Side effects) Doses Preparations Administration الاستخدامات العلاجية التفاعلات الدوائية الضارة دواعي الإستعمال

4 Drug Chemical substance Alters body functions
Can be used for, prevention, treatment or diagnosis or suppression of physiological process

5 Drug Development Drug Discovery Evaluation in Animals
Evaluation in Humans

6 Evaluation in Animals Pharmacologic Profile Safety & Toxicity Studies

7 Safety & Toxicity Studies
Acute Toxicity studies Subacute Toxicity studies Chronic Toxicity studies

8 Evaluation in Humans Phase I Small number of healthy volunteers Phase II Small number of patients Phase III Large number of patients Phase IV Post-marketing surveillance & post-licensing studies additional efficacy & toxicity

9 (official or approved name)
Drug Nomenclature Chemical name Acetylsalicylic acid Generic name Aspirin (official or approved name) Trade name Aspocid, Rivo (The commercial )

10 Pharmacopeia A book describing drugs, chemicals, and medicinal preparations Issued by an officially recognized authority Serving as a standard

11 Essential medicines (drugs)
Drugs that satisfy the priority health care Their choice depends on their safety, efficacy and low cost Should be available at all times in adequate amounts, suitable dosage forms and low cost WHO releases a list of essential medicines and national lists for individual countries Allow improved availability of medicines, cost saving and more rational use of drugs

12 From Animal to Human!!!

13 Pharmacology Science deals with drugs Nature Body's reaction to drugs
Drug's reaction to body Therapeutic uses (Indications) Adverse drug reactions (Side effects) Doses Preparations Administration الاستخدامات العلاجية التفاعلات الدوائية الضارة دواعي الإستعمال

14 % Response Dose (Log) Dose-response curve

15 Effective dose fifty ED50
100% % of Responders 50% ED50 Dose (Log)

16 Effective dose fifty ED50
The dose that produces the desired therapeutic effect in 50% of experimental animals

17 Lethal dose fifty LD50 100% % Mortality 50% LD50 Dose (Log)

18 The dose that kills 50% of experimental animals
Lethal dose fifty LD50 The dose that kills 50% of experimental animals (2 species and 2 routes)

19 Therapeutic effect Toxicity Percentage 50% ED50 LD50 Dose (Log)

20 Therapeutic effect Toxicity Percentage 50% ED50 LD50 Dose (Log)

21 Therapeutic index (TI)
Is the ratio between ED50 & LD50 TI = LD50/ED50 Gives idea about the safety of the drug The higher the TI, the…………….the drug safer

22 Pharmacology Science deals with drugs Nature Body's reaction to drugs
Drug's reaction to body Therapeutic uses (Indications) Adverse drug reactions (Side effects) Doses Preparations Administration

23

24

25

26

27

28 Pharmacodynamics What drugs do to the organism
They are the studies of the biological effects of drugs and their mechanism of action

29 Pharmacology Science deals with drugs Nature Pharmacodynamics
Pharmacokinetics Therapeutic uses (Indications) Adverse drug reactions (Side effects) Doses Preparations Administration

30 Pharmacological Response
Response may be intended (Therapeutic Effect, Indications) Response may be unintended (Harmful) (Adverse Effect, Side effects)

31 What is the clinical importance of studying drug's Ph. kinetics & Ph
What is the clinical importance of studying drug's Ph. kinetics & Ph. dynamics

32 Mechanism (Mode) of Action of Drugs
PHARMACODYNAMICS Mechanism (Mode) of Action of Drugs Receptor mediated Non-receptor mediated

33 Receptor Specific cellular macromolecules (usually proteins)
Cell membrane or Intracellular Interact with a ligand (binding)

34 Receptor (Cont.) Sensitive Very small concentration of ligand → elicit the action Selective Each receptor has the type of ligand to interact with Specific Elicit the same response each time they interact with ligand

35 Types of ligands Agonist RESPONSE Antagonist

36 Agonist Vs Antagonist Agonist binds to receptors to activate it
Agonist possess affinity and efficacy Antagonist binds to receptors without activating it Antagonist possess affinity with no efficacy

37 Drugs work as agonists or antagonists?

38 How the receptor elicit a response?

39 Signal Transduction Inactive Active

40

41 Tyrosine Kinase linked Regulating Transcription
Signal Transduction Systems Tyrosine Kinase linked Ion Channels G protein- Coupled Regulating Transcription NO receptors NO

42 Tyrosine Kinase linked Regulating Transcription
Signal Transduction Systems Tyrosine Kinase linked Ion Channels G protein- Coupled Regulating Transcription NO receptors NO

43 Tyrosine Kinase linked Regulating Transcription
Signal Transduction Systems Tyrosine Kinase linked Ion Channels G protein- Coupled Regulating Transcription NO receptors NO

44 Tyrosine Kinase linked Regulating Transcription
Signal Transduction Systems Tyrosine Kinase linked Ion Channels G protein- Coupled Regulating Transcription NO receptors NO

45 Tyrosine Kinase linked Regulating Transcription
Signal Transduction Systems Tyrosine Kinase linked Ion Channels G protein- Coupled Regulating Transcription NO receptors NO

46 At the end I am expecting from you to be able to
Define and understand basic terms in pharmacology, Pharmacokinetics, Pharmacodynamics and Pharmacological actions Describe the major animal and clinical studies carried out in drug development Define effective dose 50 and lethal dose 50 Specify types of ligands Describe the different signaling mechanisms for drug receptor interaction and their impact on drugs actions

47


Download ppt "By Amany Helmy Hasanin Assistant Professor of Clinical Pharmacology"

Similar presentations


Ads by Google